The Benefits of Semaglutide and Tirzepatide (GLP-1) and Alcohol Use Disorder The glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide has made headlines as a US Food and Drug Administration (FDA)–approved treatment for type 2 diabetes (Ozempic) and obesity...
